生物活性 | |||
---|---|---|---|
描述 | Thymopentin is a biologically active peptide secreted mainly by the epithelial cells of thymic cortex and medulla. Thymopentin is an effective immunomodulatory agent with a short plasma half-life of 30 seconds. Thymopentin enhances the generation of T-cell lineage derived from human embryonic stem cells (hESCs). Thymopentin enhances T-cell lineage differentiation from hESCs in vitro by mimicking thymus peptide environment in vivo[1]. Thymopentin (TP5), a synthetic immunomodulator pentapeptide (Arg-Lys-Asp-Val-Tyr) with an excellent safety profile in the clinic, protects mice against cecal ligation and puncture (CLP)-induced sepsis, as shown by improved survival rate, decreased level of pro-inflammatory cytokines and reduced ratios of macrophages and neutrophils in spleen and peritoneum[2]. TP5 (Thymopentin) exerts a protective effect on DSS(Dextran sulfate sodium)-induced colitis by triggering the production of IL-22 in both innate and adaptive lymphocytes[3]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02686554 | - | Recruiting | December 2019 | Germany ... 展开 >> Charité University Medicine Recruiting Berlin, Germany, 10117 Contact: Oliver Peters, MD +4930450517628 oliver.peters@charite.de 收起 << | |
NCT00865501 | Primary Hypertension | Phase 3 | Completed | - | Germany ... 展开 >> University Erlangen-Nürnberg, Nephrology and Hypertension Erlangen, Germany, 91054 收起 << |
NCT00138944 | Essential Hypertension | Phase 3 | Completed | - | Germany ... 展开 >> CRC Medical Department IV Erlangen, Germany, 91054 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.47mL 0.29mL 0.15mL |
7.36mL 1.47mL 0.74mL |
14.71mL 2.94mL 1.47mL |
参考文献 |
---|